[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369955-105":59,"doc-detail-369955-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lactate-dehydrogenase-a-is-a-crucial-biomarker-that-affects-the-prognosis-chemotherapy-effect-and-immune-infiltration-of-breast-cancer","Lactate dehydrogenase A is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer","","Lactate dehydrogenase A (LDHA) is analyzed as a molecular driver of tumor growth, metabolism, invasion, and treatment response in breast cancer. The study clarifies how LDHA expression relates to prognosis and therapy outcomes by integrating TCGA and multiple public databases, evaluating tumor mutational burden, immune infiltration, immune checkpoints, drug sensitivity, and enrichment of metabolic pathways. It further tests serum LDH association with pathological complete response after neoadjuvant chemotherapy and links serum LDH to mortality risk using NHANES data.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lactate-dehydrogenase-a-is-a-crucial-biomarker-that-affects-the-prognosis-chemotherapy-effect-and-immune-infiltration-of-breast-cancer/369955/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lactate-dehydrogenase-a-is-a-crucial-biomarker-that-affects-the-prognosis-chemotherapy-effect-and-immune-infiltration-of-breast-cancer/369955.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of evaluating LDHA in breast cancer?","Question",{"text":113,"@type":114},"To determine how LDHA influences breast cancer biology and whether it can serve as a prognostic marker and predictor of therapeutic response.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which analyses were used to relate LDHA to clinical and molecular features?",{"text":118,"@type":114},"LDHA expression was assessed in TCGA, and its associations were examined with tumor mutational burden, immune infiltration, immune checkpoint molecules, and drug sensitivity, using Kaplan–Meier and bioinformatics enrichment analyses (GO, KEGG, GSEA).",{"name":120,"@type":111,"acceptedAnswer":121},"How does serum LDH relate to treatment response and mortality in the study?",{"text":122,"@type":114},"In an institutional neoadjuvant chemotherapy cohort, lower serum LDH was associated with higher rates of pathological complete response and independently predicted pCR. In NHANES, elevated serum LDH correlated with increased mortality risk.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369955,1790293743,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Xia et al. BMC Women's Health (2025) 25:497 BMC Women's Health  \n[https://doi.org/10.1186/s12905-025-04039-w](https://doi.org/10.1186/s12905-025-04039-w)  \nRESEARCH Open Access  \nLactate dehydrogenase a is a crucial   \nbiomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer  \nJing Qi Xia 1†, Yi Lin Wang 1†, Xue Lian Li 1, Jia Nan Wang 1, Fu Cheng Li 1, Si Yuan Jia 1, Yu Ling Ba 1, Dan Li Luo 1, Tian Gao 1, Zhao Ting Li 1, Min Xiao 1* and He Dou 1*  \nAbstract  \nPurpose Lactate dehydrogenase A (LDHA) is a key node in tumor growth, metabolism, and invasion and is upregulated across multiple cancers. However, the molecular mechanisms by which LDHA influences breast cancer (BC) remain unclear. We analyzed public datasets and an institutional cohort to clarify the relationship between LDHA and BC, with the aim of informing future therapeutic strategies.  \nPatients and methods Using The Cancer Genome Atlas (TCGA), we assessed LDHA expression in BC and examined its associations with tumor mutational burden (TMB), immune cell infiltration, immune checkpoint molecules, and drug sensitivity. We integrated multiple databases and used Kaplan–Meier analyses to evaluate prognostic value. To explore biological functions of LDHA, we performed Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) . We then analyzed BC patients receiving neoadjuvant chemotherapy (NAC) at Harbin Medical University Cancer Hospital to test the relationship between serum lactate dehydrogenase (LDH) and pathological complete response (pCR) . Finally, we used National Health and Nutrition Examination Survey (NHANES) data to examine the association between serum LDH and mortality.  \nResults LDHA was upregulated in BC tissues, and higher expression was significantly associated with worse overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival (DMFS) . Functional analyses indicated enrichment of metabolic pathways, such as glycolysis. LDHA expression correlated with multiple immune cell populations, suggesting involvement in the tumor immune microenvironment. Lower LDHA expression was associated with greater sensitivity to several chemotherapeutic agents. In our institutional cohort, patients with lower serum LDH were more likely to achieve pCR, and LDH was an independent predictor of pCR. In NHANES, elevated serum LDH was linked to increased mortality risk.  \n†Jing Qi Xia and Yi Lin Wang contributed equally to this article.  \n*Correspondence: Min Xiao [xiaomin@hrbmu.edu.cn](xiaomin@hrbmu.edu.cn)[ ](xiaomin@hrbmu.edu.cn)He Dou [814971937@qq.com](814971937@qq.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nXia et al. BMC Women's Health (2025) 25:497 Page 2 of 25  \nConclusion Our findings suggest that LDHA expression and serum LDH levels are promis","cbCaidglfWwc9FAL","https://ap.wps.com/l/cbCaidglfWwc9FAL","pdf",4471913,25,"English","# Abstract\n## Purpose\n## Patients and methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of evaluating LDHA in breast cancer?\",\"answer\":\"To determine how LDHA influences breast cancer biology and whether it can serve as a prognostic marker and predictor of therapeutic response.\"},{\"question\":\"Which analyses were used to relate LDHA to clinical and molecular features?\",\"answer\":\"LDHA expression was assessed in TCGA, and its associations were examined with tumor mutational burden, immune infiltration, immune checkpoint molecules, and drug sensitivity, using Kaplan–Meier and bioinformatics enrichment analyses (GO, KEGG, GSEA).\"},{\"question\":\"How does serum LDH relate to treatment response and mortality in the study?\",\"answer\":\"In an institutional neoadjuvant chemotherapy cohort, lower serum LDH was associated with higher rates of pathological complete response and independently predicted pCR. In NHANES, elevated serum LDH correlated with increased mortality risk.\"}]","Lactate dehydrogenase A is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer | PDF",1790185382,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effe57e79e825d2487b9ffa9ae099567.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08aceeb382a8543fa0481fbbb978fb04.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/266ebb4b86ebcf0844e470d768df42f1.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f4709fdba80f3864f7cbb9ccd739380.webp",980,1306]